Indian pharma CDMOs sector unfazed by proposed US tariffs: Report - The Times of India
Indian pharmaceutical CDMOs are anticipated to encounter minimal disruptions from the proposed US tariffs of 10-25 per cent. Despite the tariff concer
What's Your Reaction?